APRIL MORRIS: Open Payments
NPI 1023314812 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 31 payments from 16 companies in 2025. Trend: 2023 $247 · 2024 $107 · 2025 $1,056
Food & beverage: $944Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $291 |
| Eisai Inc. | 2 | $121 |
| Axsome Therapeutics, Inc. | 2 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Neurocrine BioSciences, Inc. | 1 | $49 |
| PFIZER INC. | 2 | $46 |
| UCB, Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| JAZZ PHARMACEUTICALS INC. | 2 | $36 |
Products named: QULIPTA, Leqembi, Symbravo, REXULTI, INGREZZA, NURTEC ODT, Nayzilam, UBRELVY.
Industry payments across MI — which companies pay providers there.
